RT Journal Article
SR Electronic
T1 Stochastic simulation of successive waves of COVID-19 in the province of Barcelona
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.12.02.21266468
DO 10.1101/2021.12.02.21266468
A1 Bosman, M.
A1 Esteve, A.
A1 Gabbanelli, L.
A1 Jordan, X.
A1 López-Gay, A.
A1 Manera, M.
A1 Martínez, M.
A1 Masjuan, P.
A1 Mir, Ll.M.
A1 Paradells, J.
A1 Pignatelli, A.
A1 Riu, I.
A1 Vitagliano, V.
YR 2021
UL http://medrxiv.org/content/early/2021/12/08/2021.12.02.21266468.abstract
AB Analytic compartmental models are currently used in mathematical epidemiology to forecast the COVID-19 pandemic evolution and explore the impact of mitigation strategies. In general, such models treat the population as a single entity, losing the social, cultural and economical specifici- ties. We present a network model that uses socio-demographic datasets with the highest available granularity to predict the spread of COVID-19 in the province of Barcelona. The model is flexible enough to incorporate the effect of containment policies, such as lockdowns or the use of protec- tive masks, and can be easily adapted to future epidemics. We follow a stochastic approach that combines a compartmental model with detailed individual microdata from the population census, including social determinants and age-dependent strata, and time-dependent mobility information. We show that our model reproduces the dynamical features of the disease across two waves and demonstrate its capability to become a powerful tool for simulating epidemic events.Competing Interest StatementThe authors have declared no competing interest.Funding StatementMB, XJ, LLM, MMar, PM, JP, IR acknowledge support from the grant 2020PANDE0180 of the programme PANDEMIES 2020, "Replegar-se per créixer: l'impacte de les pandèmies en un món sense fronteres visibles" of the Agència de Gestió d'Ajuts Universitaris i de Recerca of the Generalitat de Catalunya. LG thanks the funding from the European Union's Horizon 2020 research and innovation programme under grant agreement ID 758145. AL acknowledges the support from the Talent Research Program (Universitat Autònoma de Barcelona). PM has received funding from the Spanish Ministry of Science and Innovation (PID2020-112965GB-I00/AEI/ 10.13039/501100011033), from the Agency for Management of University and Research Grants of the Government of Catalonia (project SGR 1069), and also received support from Ajuntament de Barcelona. MMan acknowledges support from Marie Sklodowska-Curie grant agreement ID 6655919. VV has been partially supported by the H2020 programme and by the Secretary of Universities and Research of the Government of Catalonia through a Marie Sklodowska-Curie COFUND fellowship -- Beatriu de Pinós programme ID 801370.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The Ethics Committee on Animal and Human Research of the Universitat Autònoma de Barcelona (Comissión de ética en la Experimentación Animal t Humana de la Universitat Autonòma de Barcelona CEEAH, Vicerectorat de Recerca i de Transferència, Edifici A, Campus UAB, 08193 Bellaterra, Barcelona, Spain) waived ethical approval of this workI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors